FMR LLC 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Vera Therapeutics, Inc. VERA |
FMR LLC | 2,785,284 5.080% |
10,912 (+0.39%) |
Filing |
| 2024-02-09 10:05 am Sale |
2024-02-08 | 13G | Vera Therapeutics, Inc. VERA |
FMR LLC | 2,774,372 6.243% |
-533,238 (-16.12%) |
Filing |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Vera Therapeutics, Inc. VERA |
FMR LLC | 3,307,610 7.463% |
-841,036 (-20.27%) |
Filing |
| 2023-02-09 12:39 pm Purchase |
2023-02-09 | 13G | Vera Therapeutics, Inc. VERA |
FMR LLC | 4,148,646 15.000% |
1,003,444 (+31.90%) |
Filing |
| 2022-02-09 10:01 am Purchase |
2022-02-08 | 13G | Vera Therapeutics, Inc. VERA |
FMR LLC | 3,145,202 14.999% |
73,306 (+2.39%) |
Filing |
| 2021-06-10 11:37 am Purchase |
2021-06-09 | 13G | Vera Therapeutics, Inc. VERA |
FMR LLC | 3,071,896 15.229% |
3,071,896 (New Position) |
Filing |